首页 | 本学科首页   官方微博 | 高级检索  
检索        

艾司氯胺酮对子宫切除术患者术后焦虑抑郁的影响
引用本文:吴春霞,邹澜,吴春峰.艾司氯胺酮对子宫切除术患者术后焦虑抑郁的影响[J].药学与临床研究,2024,32(1):40-44.
作者姓名:吴春霞  邹澜  吴春峰
作者单位:江苏大学附属武进医院、徐州医科大学武进临床学院,常州市妇幼保健院,江苏大学附属武进医院、徐州医科大学武进临床学院
摘    要:目的:观察艾司氯胺酮对子宫切除术后患者焦虑抑郁的影响。方法:选择全身麻醉下行腹腔镜子宫切除手术的患者160例。采用数字表法随机分为艾司氯胺酮组(E组)和对照组(C组),每组80例。E组在手术切皮前5 min给予单剂量艾司氯胺酮0.4 mg·kg-1(生理盐水稀释10 mg·mL-1),C组在同样的时间输注等量的生理盐水。采用蒙哥马利-阿斯伯格抑郁量表(MADRS)、广泛性焦虑量表(GAD-7)对患者术前1天、术后第1天和第7天情绪进行评价。记录入室后5 min、插管即刻、切皮和拔管时的血压、心率,术中麻醉药物用量,术毕即刻、术后2 h和24 h视觉模拟评分(VAS)、舒适评分(BCS)及术后不良反应和住院时间。结果:和C组相比,E组术后24 h MARDS评分明显降低(P <0.05)。E组术后24 h MARDS评分> 11的人数显著少于C组(P <0.05)。两组术后24 h和7 d的GAD-7评分差异无统计学意义(P> 0.05)。E组术中瑞芬太尼用量低于C组,差异具有统计学意义。术后2 h的VAS评分E组低于C...

关 键 词:艾司氯胺酮  妇科  抑郁  焦虑
收稿时间:2023/10/22 0:00:00
修稿时间:2024/3/2 0:00:00

Effects of Esketamine on Postoperative Anxiety and Depression in Patients Undergoing Hysterectomy
wuchunxi,zoulan and wuchunfeng.Effects of Esketamine on Postoperative Anxiety and Depression in Patients Undergoing Hysterectomy[J].Pharmacertical and Clinical Research,2024,32(1):40-44.
Authors:wuchunxi  zoulan and wuchunfeng
Abstract:Objective: To observe the effects of esketamine on anxiety and depression in patients after hysterectomy. Method: A total of 160 patients for laparoscopic hysterectomy under general anesthesia were randomly divided into group E and C by a digital table method, with 80 in each group. Patients in group E were given a single dose of esketamine (0.4 mg·kg-1, diluted with normal saline to 10 mg·mL-1) 5 min before surgical incision, and patients in group C were given the same dose of normal saline at the same time. The Montomery-Ashberg Depression Rating Scale(MARDS) and Generalized Anxiety Disorder7-item scale (GAD-7) were used to evaluate the mood of patients 1 day before surgery and 1 day and 7 days after surgery. The blood pressures and heart rates were recorded 5 minutes after entry, immediately after intubation, during skin incision and extubation. Data of intraoperative anesthetic dosage, visual analogue scale (VAS) and Bruggrmann comfort scale(BCS) immediately, 2 h and 24 h postoperative, postoperative adverse reactions and length of stay were recorded. Results: Compared with group C, MARDS scores of group E significantly decreased at 24 h after surgery (P < 0.05). The number of patients with postoperative MARDS >11 in group E was significantly less than that in group C (P < 0.05). There were no significant differences in GAD-7 scores at 1 d and 7 d after surgery between the two groups(P > 0.05). The intraoperative dosage of remifentanil in group E was significantly lower than that in group C (P < 0.05). The VAS score of group E was significantly lower than that of group C at 2 h after surgery (P < 0.05). There was no significant difference in postoperative adverse reactions between the two groups(P > 0.05). Conclusion: Esketamine at a subanesthetic dose before surgery can reduce the incidence and severity of depression on the first day after surgery, has a good analgesic effect in patients two hours after surgery and does not significantly increase postoperative adverse reactions, which is worthy of clinical promotion.
Keywords:Esketamine  Gynecology  Depression  Anxiety
点击此处可从《药学与临床研究》浏览原始摘要信息
点击此处可从《药学与临床研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号